Sign in

CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
471851754
Phone
240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-12-23 Vasista Vittal Chief Financial Officer Sale −21,124 $50.01 $1.1M 136,400
2020-12-23 Mills Kenneth T. President and CEO Option exercise +4,500 $0.85 $4K 245,500
2020-12-23 Mills Kenneth T. President and CEO Sale −4,500 $50.00 $225K 241,000
2020-12-23 Mills Kenneth T. President and CEO Option exercise · Employee Stock Option (Right to Buy) −4,500 55,670
2020-12-16 Mills Kenneth T. President and CEO Option exercise +15,000 $0.85 $13K 256,000
2020-12-16 Mills Kenneth T. President and CEO Sale −15,000 $45.00 $675K 241,000
2020-12-16 Mills Kenneth T. President and CEO Option exercise · Employee Stock Option (Right to Buy) −15,000 60,170
2020-12-11 Vasista Vittal Chief Financial Officer Sale −14,916 $40.17 $599K 157,524
2020-12-10 Vasista Vittal Chief Financial Officer Sale −22,584 $40.06 $905K 172,440
2020-12-10 Mills Kenneth T. President and CEO Option exercise +4,500 $0.85 $4K 245,500
2020-12-10 Mills Kenneth T. President and CEO Sale −4,500 $40.00 $180K 241,000
2020-12-10 Mills Kenneth T. President and CEO Option exercise · Employee Stock Option (Right to Buy) −4,500 75,170
2020-08-06 Fox Allan M. Director Gift −90,000 1,324,110
2020-08-06 Fox Allan M. Director Gift +90,000 315,000
2020-07-27 Fox Allan M. Director Gift −225,000 1,414,110
2020-07-27 Fox Allan M. Director Gift +225,000 225,000
2020-07-15 Vasista Vittal Chief Financial Officer Option exercise +3,259 $13.09 $43K 209,974
2020-07-15 Vasista Vittal Chief Financial Officer Sale −14,950 $40.10 $599K 195,024
2020-07-15 Vasista Vittal Chief Financial Officer Option exercise · Employee Stock Option (Right to Buy) −3,259 14,115
2020-06-30 Danos Olivier Chief Scientific Officer Grant or award +641 $31.31 $20K 7,443

Page 21 of 25 · 494 trades